CMT1A duplicated region transcript 8 (CDRT8)

CMT1A duplicated region transcript 8 (CDRT8) refers to a transcript within the genomic region that is duplicated in Charcot-Marie-Tooth disease type 1A, a hereditary peripheral neuropathy. Despite bearing a formal gene-like name, there is no reliable evidence in scientific databases or biomedical literature that CDRT8 encodes a well-characterized protein, serves as a receptor, or presents any functional relevance as a therapeutic target. The lack of information and use of a nonstandard naming convention suggests this entry is either a speculative genomic transcript or annotation with no current biological or therapeutic significance. No aliases, molecular family, biological function, disease roles, associations with drugs, mechanism of action, biomarker utility, or safety issues are documented in available sources. It should not be considered a valid target in the context of drug discovery, molecular biology, or translational medicine. If you intended to refer to a different molecule/receptor (for example, the CD8 co-receptor), let me know, as CDRT8 does not map to any such entity[1][2][3].